title: The differences in the pharmacological profiles of various benzodiazepine recognition site ligands may be associated with GABAA receptor structural diversity.
authors.affiliation: Fidia-Georgetown Institute for the Neurosciences, Washington, D.C. 20007.
authors.forename: A
authors.initials: A
authors.lastname: Guidotti
authors.forename: M D
authors.initials: MD
authors.lastname: Antonacci
authors.forename: P
authors.initials: P
authors.lastname: Giusti
authors.forename: M
authors.initials: M
authors.lastname: Massotti
authors.forename: M
authors.initials: M
authors.lastname: Memo
authors.forename: J L
authors.initials: JL
authors.lastname: Schlichting
mesh_terms: D000494:Allosteric Regulation; D000818:Animals; D014151:Anti-Anxiety Agents / Q000378:metabolism*; D001569:Benzodiazepines; D008024:Ligands; D015394:Molecular Structure; D011963:Receptors, GABA-A / Q000145:classification / Q000187:drug effects* / Q000378:metabolism
chemical_list: D014151:Anti-Anxiety Agents; D008024:Ligands; D011963:Receptors, GABA-A; D001569:Benzodiazepines